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Abstract. Dengue virus (DENV) was reintroduced to Peru in the 1990s and has been reported in Puerto Maldonado
(population ~65,000) in the Peruvian southern Amazon basin since 2000. This region also has the highest human migra-
tion rate in the country, mainly from areas not endemic for DENV. The objective of this study was to assess the propor-
tion of household income that is diverted to costs incurred because of dengue illness and to compare these expenses
between recent migrants (RMs) and long-term residents (LTRs). We administered a standardized questionnaire to per-
sons diagnosed with dengue illness at Hospital Santa Rosa in Puerto Maldonado from December 2012 to March 2013.
We compared direct and indirect medical costs between RMs and LTRs. A total of 80 participants completed the survey,
of whom 28 (35%) were RMs and 52 (65%) were LTRs. Each dengue illness episode cost the household an average of
US$105 (standard deviation [SD] = 107), representing 24% of their monthly income. Indirect costs were the greatest
expense (US$56, SD = 87), especially lost wages. The proportion of household income diverted to dengue illness did not
differ significantly between RM and LTR households. The study highlights the significant financial burden incurred by
households when a family member suffers dengue illness.
BACKGROUND
Dengue virus (DENV) is a Flavivirus with broad global dis-
tribution and is considered as the arbovirus with the most
important public health impact.1 DENV infection is character-
ized by fever and other nonspecific symptoms, although it is
estimated that a large proportion of infections are asymptom-
atic.2–4 Infection ranges from mild to severe disease, which may
lead to hospitalization. Hospital stay lasts for 6 days on average.
Children and infants usually have the most severe forms of the
disease in hyperendemic areas.5 DENV is transmitted by the
mosquito Aedes aegypti mainly in urban settings, while Aedes
albopictus has been implicated in rural areas.6,7 The distribution
of DENV and its vectors have continued to expand across
diverse environments worldwide,8,9 changing its epidemiology
and evolving into an important cause of morbidity and mortal-
ity, especially in developing countries.1,10 The main control
strategy remains focused on vector control,9,11–14 despite grow-
ing efforts to develop a vaccine.15,16
Studies of cost of illness became increasingly important in
the past two decades to assess the use of resources in health
care and prioritize diseases with larger burdens.17 Previous
assessments that measure the economic impact of DENV
have mainly focused on the burden to the health-care system,
which can ascend to US$27.4 million per year.18 Other studies
have reported total costs at the societal level between US$1
and US$4 million in the period between 2000 and 2007,
respectively, for all the Americas.19 However, the perspectives
of these studies, either at the societal, health-care system or at
governmental level,20 do not reflect or describe clearly the
economic burden of dengue illness on the patients or their
households, nor what factors may influence this burden.
DENV was reintroduced into Peru in the 1990s in the
northern Amazonian region of Loreto21,22 and has since
become endemic in virtually all tropical areas of the country.
The current countrywide incidence of DENV without com-
plications has been estimated to be 94.2/100,000 people.23–26
Madre de Dios (Figure 1) has the highest rate of migration
in Peru, mainly from the neighboring regions of Cusco and
Puno, for occupational perspectives.27,28 These areas are
mostly non-endemic for DENV.
Previous studies have shown the disadvantages and vulnera-
bilities faced by migrants in comparison to native workers in
different settings, ranging from lack of health awareness,
disproportionally lower income, and invisible costs shouldered
by migrants such as barriers to access better-paid jobs.29,30
The sparse information existing assessing the complex process
of migration and health-related outcomes make Puerto
Maldonado and its particular conditions an illustrative area
of study in terms of the differential economic pressure that
dengue illness may exert across the social structure of the city.
Health insurance in Peru is provided through both the pub-
lic and private sector. The public sector insurance is divided
into indirect (i.e., subsidized) and direct contributions. The
former is inexpensive universal coverage called “Integral
Health Insurance” (SIS, for the acronym in Spanish). This
insurance is directed to people living in poverty (covers 36%
of the population) and subsidizes outpatient visits, hospitaliza-
tion, laboratory exams, and medicines. The direct contribution
system is for households that contribute to social security
(called EsSalud) through their employers or directly as auton-
omous workers (covers 23% of the population). In addition to
health-care expenses, EsSalud also includes sick leave cover-
age and a pension. Insurance through the private sector and
armed forces covers 5% of the population. The population
with no coverage is approximately 36%.31,32
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The objective of this study was to assess the proportion of
household income that was diverted to cover the costs incurred
because of dengue illness and to compare these expenses
between recent migrants (RMs) to the city and long-term resi-
dents (LTRs) in Puerto Maldonado. We speculated that RMs
andLTRsmay have different access to health care, possibly with
fewer RMs contributing to EsSalud through the formal labor
force and thus paying for health care either out of pocket or
by SIS. A secondary objective was to describe the demographic
and socioeconomic features of the population of Puerto
Maldonado according to their migration status. Results from
this study provide essential information on the economic burden
of dengue illness at the household level, indicating the real
impact on individuals and families, and help to assess the cost
benefit of future vaccine efforts15,16,33–35 and continuing vector
control strategies.
METHODS
Data collection. Potential research subjects were identified
at the local hospital where dengue cases from the area are
referred. A field worker contacted patients of all ages who had
been diagnosed with dengue fever, dengue with warning symp-
toms, or dengue hemorrhagic fever, including both hospital-
ized and outpatients. The field worker briefly explained the
study and collected contact information with the patient’s con-
sent. The field worker then arranged a visit to the participant’s
home to explain the study, perform the informed consent pro-
cess, and administer a standardized questionnaire on house-
hold characteristics, income, financial expenses, care-seeking
behavior (i.e., where did they seek health care, how many
times did they go). Visits were performed within a month since
the diagnosis of dengue illness to diminish recall bias. The sur-
vey was conducted between December 2012 and March 2013,
which is typically the peak season for dengue illness in the
Madre deDios Region.
RMs were defined as persons who had been living in Puerto
Maldonado for fewer than 5 years and LTRs were those who
had been stationed in the city for 5 years or more. This cutoff
was selected on the basis of the more recent information
available on migration and place of residence from a 2007
census in Peru, which had a specific question regarding place
of residence in the previous 5 years.27
Cost-of-illness estimation. The perspective selected was that
of participants and their families.20 We estimated direct cost of
medical treatment, other nonmedical direct costs, and indirect
costs. Direct medical costs included out-of-pocket payments for
items such as medical appointments, laboratory exams, cost of
hospitalization, and medicines. Direct nonmedical costs com-
prised transportation to the health-care facility. Indirect costs
were lost wages from the patient or, in the case of children, the
caregiver.We estimated daily lost wages based on theminimum-
wage in the case of nonpaid activities, such as for housewives or
retirees who lacked social security or similar insurance. We used
the exchange rate from the Banco Central de Reserva del Peru
for the period of December 1, 2012–March 1, 2013 (www.bcrp
.gob.pe), which was 2.56 Peruvian nuevos soles to 1U.S. dollar.
Statistical analysis. The proportion of household income
devoted to dengue illness expenses by migration status was
appraised. Data were initially evaluated using descriptive
FIGURE 1. Puerto Maldonado in Madre de Dios, Peru.
FIGURE 2. Total costs incurred by patients (in U.S. dollar).
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statistics. We used the Shapiro–Wilk test to assess for normality.
K-sample and Mann–Whitney non-parametric tests were
performed to assess differences in median and average income
and cost of illness between RMs and LTRs. Also, χ2 analysis,
with Fisher’s exact adjustment as appropriate, was used to test
the associations with occupation of participants as well as the
severity of dengue illness. A wealth index (WI) was created
to assess household wealth and included variables related to
resources, construction materials of the house, and access to
services such as running water, sewer, and garbage collection
(see Supplemental Appendix 1 for details).36–38 Higher values
indicated more affluence. Statistical analysis was performed
using Stata version 12.1 (StataCorp LP, College Station, TX).
Ethical aspects. Informed consent was obtained from all
adult participants and from the parents or legal guardians of
minors. The study was approved by the Institutional Review
Boards from the NavalMedical ResearchUnit No. 6 and Johns
Hopkins Bloomberg School of Public Health.
RESULTS
General characteristics of the study population. A total of
80 subjects participated in the survey; Table 1 shows the
general demographic characteristics of the study population.
Of the study participants, 26 (32%) were native to Puerto
Maldonado, but only 28 (35%) of those who were nonnative
met the criterion for RM classification.
Among the participants who were nonnative to Puerto
Maldonado, the majority migrated from Cusco (33%), other
areas in Madre de Dios (22%), and Puno (10%). On average,
current residents who were nonnative to Puerto Maldonado
have been living in the city for 9.5 years (median = 5.2 years,
standard deviation [SD] = 11.4). There was no difference in
mean age regarding migration status (P = 0.117). However,
median age was lower among RMs (23.5, SD = 20.3) than LTRs
(31.5, SD = 16.1), which was significant using the K-sample test
for the equality of medians (P = 0.035).
Income, occupation, assets, and WI. Approximately half
(25/52) of LTRs and one-third (9/28) of RMs had received
payment for their main occupation in the week before
administration of the questionnaire, but this difference was
not statistically significant (P = 0.122). The average monthly
household income for participants was US$618.2, ranging from
US$39.1 to US$1,562.6. Nonetheless, the average household
income for RMs was approximately US$507.8, about US$136.7
lower than that of LTR families (P = 0.041). Neither the
household heads nor the cases interviewed showed a signifi-
cant difference in education level associated with their RM
or LTR status (P = 0.651 and 0.283, respectively).
RMs and LTRs showed differences in access to public ser-
vices and household construction materials (Table 2): RMs
were more likely to lack running water (P = 0.020) and gar-
bage collection services (P = 0.010). They more frequently
reported burning or burying garbage and using a latrine in
contrast to having indoor plumbing, although this was not
significant (P = 0.066). The WI ranged between 0.410 and
1.868 with a mean of 1.319 for RMs, in contrast to 1.471 for
LTRs (P = 0.003).
Dengue illness, use of and access to health care. About a
quarter of all DENV episodes were classified as dengue with
TABLE 1
General characteristics of the study population
Total RM LTR
P valueN % N % N %
Sex 1.000
Female 44 55 18 64 26 50
Male 36 45 10 36 26 50
Age
N 80 28 52 0.117
Mean, median, SD 32.1, 27.0, 17.6 29.7, 23.5, 20.3 33.3, 31.5, 16.1
Occupation 0.012
Housewife 21 26 7 25 14 27
Student 15 19 10 36 5 10
Other 11 14 0 0 11 21
Professional activity 10 13 4 14 6 12
Mining 7 9 3 11 4 8
Agriculture 6 8 3 11 3 6
Administrative/technical activity 6 8 1 4 5 10
Forestry 4 5 0 0 4 8
Education 0.283
None 6 8 4 14 2 4
Elementary school 17 21 6 21 11 21
Middle and high school 36 45 12 43 24 46
Technical school 9 11 1 4 8 15
University 12 15 5 18 7 13
Dengue diagnosis 0.171
Dengue fever 59 74 18 64 41 79
Dengue with alarm signs* 20 25 9 32 11 21
Dengue hemorrhagic fever 1 1 1 4 0 0
Origin –
Natives to Puerto Maldonado† 26 33 2 8 24 46
Nonnatives to Puerto Maldonado 54 68 24 92 28 54
LTR = long-term residents; RM = recent migrants; SD = standard deviation.
*Dengue with warning signs: abdominal pain, persistent vomiting, clinical fluid accumulation, mucosal bleed, lethargy/restlessness, liver enlargement of more than 2 cm and an increase in
hematocrit plus decrease in platelet count.
†Two participants were born in PEM and had returned within the previous 5 years.
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warning signs (Table 3),with no differences in the fre-
quency of underlying health problems between RMs and
LTRs (P = 0.287). RMs required caregivers more frequently
than LTRs (P = 0.082). Approximately 64% of participants
reported being incapacitated because of illness. The number
of days lost (from work, housework, or school) for each
dengue illness episode averaged 5.1, ranging from 1 to 30 days.
More than 60% of respondents did not have health insur-
ance, a slightly higher proportion among RMs, but nonsignif-
icant. There were no significant differences between groups
with regard to frequency of utilization of health services or
the types of services used.
Cost of illness. Each dengue episode cost an average of
US$105.3: US$47.6 direct costs, US$2.3 nonmedical direct
costs (transportation), and US$55.5 indirect costs (Table 4).
The larger proportion of expenses was aggregated in direct
costs (49%) and indirect costs (35%). However, indirect
costs—which were wages lost because of illness—were more
than half of total expenses (52%) when these costs were
reported (Figure 2). Costs incurred by RMs and LTRs were
similar (Table 4). The mean total cost for patients who
were hospitalized was US$149.7, in contrast to US$68.8 for out-
patients (P < 0.001). Direct medical costs, direct nonmedical
costs, and indirect costs were US$29.3, US$2.4, and US$35.5,
respectively, for outpatients, while it averaged US$68.8, US$2.2,
and US$78.7, respectively, for hospitalized cases. Participants
who had health insurance had fewer expenses than those who
did not have it (P = 0.010), but the difference was not relevant
after controlling for severity of illness (P = 0.060.) The main
difference between insured and uninsured patients were direct
costs, which came up to almost US$60 for those who did not
have any kind of insurance compared with ~US$30 on aver-
age for participants who had coverage (P < 0.001). The mean
total cost for patients with dengue without warning signs
was US$97.4 and those with warning signs was US$127.5
(P = 0.122) (Table 5).
The proportion of monthly household income that was
diverted to dengue-related expenses or lost wages because of
illness was approximately 24% (SD 36.0), ranging from no
expenses to spending all household income on a dengue illness
TABLE 2
Household characteristics and access to utilities by migration status
Total (N = 80) RM (N = 28) LTR (N = 52)
P value*N % N % N %
Services
In-house water plumbing 63 79 18 64 45 87 0.020
Garbage collection service 64 80 18 64 46 88 0.010
Sewage connection 56 70 16 57 40 77 0.066
Shared bathroom with
other family or business
12 15 4 14 8 15 1.000
Flooring material
Wood 6 8 5 18 1 2 0.018
Dirt 18 23 8 29 10 19 0.340
Cement/concrete 49 61 14 50 35 67 0.130
Tiles 7 9 1 4 6 12 0.412
Roofing material
Cement/concrete 6 8 1 4 5 10 0.659
Corrugated iron 72 90 26 93 46 88 0.706
Palm trees 2 3 1 4 1 2 1.000
Wall material
Wood 51 64 18 64 33 63 0.942
Cement/concrete 23 29 8 29 15 29 0.979
Other 6 8 2 7 4 8 1.000
*χ2 or Fisher’s exact test.
TABLE 3
Characteristics of dengue illness episodes
Total (N = 80) RM (N = 28) LTR (N = 52)
P valueN % N % N %
Dengue diagnosis
Dengue fever 59 74 18 64 41 79 0.171
Dengue with alarm signs* 20 25 9 32 11 21
Dengue hemorrhagic fever 1 1 1 4 0 0
Underlying conditions
Presence 16 20 4 14 12 23 0.397
Absence 64 80 24 86 40 77
Need for caregiver
Yes 29 36 13 46 16 31 0.223
No 51 64 15 54 36 69
Type of care
Outpatient 37 46 12 43 31 60 0.167
Hospitalization 43 54 16 57 21 40
LTR = long-term residents; RM = recent migrants.
*Dengue with alarm signs: abdominal pain, persistent vomiting, clinical fluid accumulation, mucosal bleed, lethargy/restlessness, liver enlargement of more than 2 cm, and an increase in
hematocrit plus decrease in platelet count.
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episode. The proportion of monthly household income per
dengue illness episode was similar between LTRs and RMs
(P = 0.462), although RMs diverted a higher proportion of
their income in each dengue episode (31%). We did not find
any difference in the proportion of expenses by severity of
disease. Only one participant reported incurring in debt because
of dengue illness.
Finally, with the average cost of each dengue illness episode,
we estimated the total cost of reported dengue cases for
the region of Madre de Dios in 2012, which had the second
highest annual incidence rate in the country: 1,604/100,000
people.39 The total cost was US$216,076, burdened by the
households of 2,052 dengue cases reported forMadre de Dios.
DISCUSSION
Despite previous larger studies to assess the economic burden
of DENV in Latin America,10,40 there is sparse information
regardingDENV costs at the household level in the region. Sim-
ilarly, there has not been a previous assessment of expenses
incurred because of DENV in Peru, although certain regions,
such as Madre de Dios, have a disproportionate burden of the
disease when compared with national rates.26
We found no significant differences between the costs
incurred by RMs and LTRs. Direct medical costs were approxi-
mately US$48, which was higher than the total costs (US$27,
approximately 23% of the average monthly income41) esti-
mated in a study from Kampong Cham Province, Cambodia,42
and higher than US$35 averaged for direct costs of hospitalized
cases of dengue illness in Colombia.43 It is also in excess of
the highest cost for hospitalization with dengue hemorrhagic
fever (US$39.1, approximately 12% of the average monthly
income44) as reported from a cohort of children in Thailand45 or
the average cost (approximately US$24) for a population of
children and adults in the same country.46 In contrast, these
costs were much lower than those reported for Puerto Rico
ranging from US$1,764 to US$764 for hospitalized patients
and ambulatory cases, respectively, or for Colombia where
ambulatory cases averaged US$154.8 and hospitalized cases
US$270.8.43,47 The direct costs of dengue illness that we cal-
culated were similar to those estimated in the state of Zulia,
Venezuela,48 and were less than those estimated for Peru by
Shepard and others since they used a societal perspective. The
latter study calculated US$259 for outpatients and US$723 for
hospitalized cases.19 A study performed in Vietnam estimated
total costs at US$167.8 per hospitalized case,49 closer to the
findings in this study for patients who required hospitalization
(US$135.8). It is remarkable, though that research conducted
in southeast Asia reported a large proportion of participants
contracting debt.42 This is in contrast to the findings in this
study, in which only one patient from Puerto Maldonado
contracted debt because of dengue illness.
The total expenditure for DENV episode accounted for
approximately a quarter of the monthly household income, on
average. This proportion was lower than 37% as reported for
Thailand,46 but comparable to Vietnam.49 This research, how-
ever, was unable to find or link a higher proportion of monthly
household income diverted to DENV expenditures from RM
households compared with LTR households. Data collected
from the investigation suggested that households of LTRs have
higher income thanRMs, similar to previous findings.29
The length of dengue illness per episode was comparable to
what has been reported in other studies.45,46 Similarly, the num-
ber of contacts a dengue patient makes with health-care facili-
ties for each episode of dengue, 1.5 on average, is similar to
what has been estimated before in different settings as well.42 In
terms of severity, almost half of dengue cases were hospitalized
(46%). Although this percentage is lower than what has been
shown in similar studies,42 hospitalization was related only to
having been diagnosed with dengue with warning signs, but
not with the preexistence of a chronic condition (i.e., diabetes,
hypertension). According to the World Health Organization
Guidelines for Diagnosis, Treatment, Prevention andControl of
Dengue, the presence of comorbidities corresponds to admis-
sion criteria for dengue treatment.9 Therefore, this concerning
finding should be evaluated through different means to assess
the protocol and practices in place for the hospitalization of
patients with dengue.
Finally, the availability of public services such as garbage
collection, running water, and connection to sewers was dif-
ferent between RMs and LTRs, with insufficient coverage
among RMs. This is probably related to the settling areas
TABLE 4
Detail of direct and indirect costs (in US$) by migration status
Type of cost
Total RM LTR
P valueMean SD Median IQR Mean SD Median IQR Mean SD Median IQR
Direct costs 47.6 42.5 42.3 67.3 47.3 42.4 32.4 60.8 47.7 42.9 43.5 64.8 0.911
Nonmedical direct costs 2.3 1.6 1.6 1.9 2.3 1.5 1.6 1.9 2.3 1.7 1.7 1.9 0.931
Indirect costs 55.5 86.5 24.4 67.1 48.4 58.3 24.4 67.1 59.3 98.8 24.4 67.1 0.622
Total costs 105.3 106.1 77.6 108.8 97.9 72.1 92.8 108.0 109.3 120.9 75.9 104.4 0.705
IQR = interquartile range; LTR = long-term residents; RM = recent migrants; SD = standard deviation.
TABLE 5
Detail of direct and indirect costs (in U.S. dollar) by diagnosis
Type of cost
Total Classic dengue Dengue with warning signs or severe
P valueMean SD Median IQR Mean SD Median IQR Mean SD Median IQR
Direct costs 47.6 42.5 42.3 67.3 41.2 38.7 33.2 50.0 65.5 48.3 70.1 114.6 0.033
Nonmedical direct costs 2.3 1.7 1.6 1.9 2.1 1.5 1.6 2.3 2.7 1.9 1.6 1.6 0.260
Indirect costs 55.5 86.5 24.4 67.1 54.1 86.2 24.4 73.2 59.3 89.4 24.4 36.6 0.413
Total costs 105.3 106.1 77.6 108.8 97.4 102.3 69.1 109.0 127.5 115.5 98.2 70.1 0.122
IQR = interquartile range; SD = standard deviation.
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of RMs, which may be in newer locations in the city and
grow in an unplanned manner similar to other urban areas in
developing countries.50–52 Differential risk of dengue because
of location in urban settings has been described before in
other studies3,30,53–56 and has been assessed with countrywide
data in Peru, linking poor access to running water as a risk
factor for DENV.26
This study has several limitations, including a small sample
size. It was originally estimated to detect a 10% difference in
the proportion of income diverted to dengue between RMs
and LTRs. Although approximately 20% of household
income is diverted to dengue in LTR households and 31%
for RM households, this difference was not significant in the
study. Similarly, we lacked data to assess expenditures of the
household for more comprehensive and detailed understand-
ing of the impact of dengue illness. Similarly, the information
collected for this study pertains to cases with enough symp-
toms to seek health care. Therefore, this is a lower-bound
estimate of the true impact since some illness may not be
reported but may influence productivity and household income.
Similarly, there may be economic barriers to accessing health
care in the first place that this study was not designed to address,
but should be evaluated.
This is the first study within the country to describe the
economic impact of dengue at the household level. The total
cost for the households of the dengue cases in the region for
2012 was US$216,076. Approximately half of these costs,
US$106,000, corresponds to direct costs, and approximately
US$75,500 were indirect costs. Similar studies are needed
to improve our understanding of the burden of this disease,
especially in the face of current efforts to develop a vaccine57
and cost-effectiveness studies that may be needed to correctly
assess the impact of these strategies.35
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